XT
HRMY icon

XTX Topco’s Harmony Biosciences HRMY Stock Holding History

XTX Topco’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.19M Buy
60,097
+38,533
+179% +$1.22M 0.03% 1031
2026
Q1 		$604K Sell
21,564
-11,456
-35% -$376K 0.01% 1850
2025
Q4 		$1.24M Sell
33,020
-10,447
-24% -$343K 0.03% 878
2025
Q3 		$1.2M Buy
43,467
+34,215
+370% +$1.18M 0.06% 458
2025
Q2 		$292K Sell
9,252
-15,247
-62% -$490K 0.01% 1453
2025
Q1 		$813K Buy
24,499
+17,683
+259% +$634K 0.04% 681
2024
Q4 		$235K Sell
6,816
-4,469
-40% -$154K 0.02% 1425
2024
Q3 		$451K Buy
+11,285
New +$396K 0.03% 887
2023
Q2 		– Sell
-16,928
Closed -$553K – 1586
2023
Q1 		$553K Buy
+16,928
New +$771K 0.12% 236
2022
Q4 		– Sell
-6,735
Closed -$298K – 1294
2022
Q3 		$298K Buy
+6,735
New +$329K 0.07% 507

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

XTX Topco's HRMY Position: Q2 2026 in Review

XTX Topco increased its Harmony Biosciences (HRMY) stake by 179% in Q2 2026, buying an estimated $1.22M and bringing the position to 60,097 shares worth $2.19M. The position accounts for 0.03% of the portfolio, ranked #1031.

XTX Topco first reported a position in HRMY in Q3 2022 and has held it in 10 quarters since. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • XTX Topco held 60,097 shares of Harmony Biosciences worth $2.19M as of Q2 2026.
  • XTX Topco bought 38,533 Harmony Biosciences shares in Q2 2026, an estimated $1.22M.
  • Harmony Biosciences made up 0.03% of XTX Topco's portfolio in Q2 2026, its #1031 holding.
  • XTX Topco first reported a position in Harmony Biosciences in Q3 2022 and has held it in 10 quarters since.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.